Enhanced regeneration and repair
iMP cells are a novel and distinct mesodermal progenitor cells discovered and isolated by Cell Therapy Limited (CTL), able to act as a potent cardio-specific cellular therapy for cardiac regeneration.
iMPs are selected on their regenerative characteristics, unique homing capabilities and immunomodulatory ability. Although MSC-like and plastic adherent, iMPs are not MSCs as defined by the ISSCR consensus definition of MSCs. iMPs possess a distinct phenotype that is optimised for immuno-modualtion and in Heartcel™ the first cardiac regeneration specific cell. As with all CTL products, iMPs are cultured in animal free (xeno-free) media conditions.